10 research outputs found
Gender, Innovation und Unternehmensentwicklung
Forschungsarbeiten stellen immer wieder fest, dass Frauen im Allgemeinen und Unternehmerinnen im Besonderen weniger innovativ sind als ihre männlichen Pendants. Häufig wird dies auch in Verbindung mit einer schwächeren Unternehmensentwicklung weiblich geführter Unternehmen gebracht. Die vorliegende Studie zeigt, dass dieser Einschätzung ein vornehmlich technologisch geprägtes Innovationsverständnis und die Fokussierung auf Brachen, die von vorneherein als innovativ betrachtet werden, zugrunde liegen. Individuelle (berufliche) Präferenzen und das vorherrschende Bild des männlichen Innovators führen jedoch dazu, dass Frauen weniger innovativ im klassischen, technologischen Sinne sind. Hinzu kommt, dass die institutionellen Rahmenbedingungen eine Teilzeitarbeit auch von selbstständigen Frauen begünstigen. Unternehmen, die in Teilzeit betrieben werden, verfügen jedoch in der Regel über geringere Ressourcen. Die Risiken, die mit einer Innovationstätigkeit verbunden sind, stellen deshalb eine größere Herausforderung dar.In innovation research, there is a wide-spread notion that women in general and women entrepreneurs in particular are less innovative than their male counterparts. This is often associated with a weaker performance of women-led firms. Our study shows that this notion is based on a limited definition and examination of innovation. In empirical research as well as in innovation funding programs, innovation is considered to be technologically based and to take place in certain, innovative sectors. Due to the perceptions of women's role in society, however, women are less prone to operate in these sectors and to engage in this specific type of innovation. Moreover, the institutional framework sets incentives for (salaried as well as self-employed women to work part-time. But a firm that is being operated on a part-time basis might miss the resources necessary to bear the risks of innovative activities
Recommended from our members
Treatment of posttraumatic stress disorder with phenytoin: An open-label pilot study
Effects of phenytoin on memory, cognition and brain structure in post-traumatic stress disorder: a pilot study
Phenytoin (Dilantin®) is an anticonvulsant used in the treatment of epilepsy. It is believed to act by modulation of glutamatergic transmission. Because the neurobiology of post-traumatic stress disorder (PTSD) has been hypothesized to involve alterations in glutamatergic transmission with subsequention neurotoxicity, we assessed the effects of phenytoin on cognition and brain structure in PTSD patients. Phenytoin was administered in an open label fashion for 3 months to nine adult patients with PTSD related to a variety of traumas, including early abuse, combat and car accidents. Subjects underwent magnetic resonance imaging for measurement of whole brain and hippocampal volume, and neuropsychological testing of memory and cognition, before and after treatment. Phenytoin treatment resulted in a significant 6% increase in right brain volume (p < 0.05). Increased hippocampal volume was correlated with reductions in symptom severity as measured by the Clinician Administered PTSD Scale and improvements in executive function as measured by the Trails test. However, treatment associated improvements in memory and cognition did not achieve statistical significance. These findings suggest that phenytoin treatment may be associated with changes in brain structure in patients with PTSD
Recommended from our members
Effects of pre-operative isolation on postoperative pulmonary complications after elective surgery: an international prospective cohort study an international prospective cohort study
We aimed to determine the impact of pre-operative isolation on postoperative pulmonary complications after elective surgery during the global SARS-CoV-2 pandemic. We performed an international prospective cohort study including patients undergoing elective surgery in October 2020. Isolation was defined as the period before surgery during which patients did not leave their house or receive visitors from outside their household. The primary outcome was postoperative pulmonary complications, adjusted in multivariable models for measured confounders. Pre-defined sub-group analyses were performed for the primary outcome. A total of 96,454 patients from 114 countries were included and overall, 26,948 (27.9%) patients isolated before surgery. Postoperative pulmonary complications were recorded in 1947 (2.0%) patients of which 227 (11.7%) were associated with SARS-CoV-2 infection. Patients who isolated pre-operatively were older, had more respiratory comorbidities and were more commonly from areas of high SARS-CoV-2 incidence and high-income countries. Although the overall rates of postoperative pulmonary complications were similar in those that isolated and those that did not (2.1% vs 2.0%, respectively), isolation was associated with higher rates of postoperative pulmonary complications after adjustment (adjusted OR 1.20, 95%CI 1.05–1.36, p = 0.005). Sensitivity analyses revealed no further differences when patients were categorised by: pre-operative testing; use of COVID-19-free pathways; or community SARS-CoV-2 prevalence. The rate of postoperative pulmonary complications increased with periods of isolation longer than 3 days, with an OR (95%CI) at 4–7 days or ≥ 8 days of 1.25 (1.04–1.48), p = 0.015 and 1.31 (1.11–1.55), p = 0.001, respectively. Isolation before elective surgery might be associated with a small but clinically important increased risk of postoperative pulmonary complications. Longer periods of isolation showed no reduction in the risk of postoperative pulmonary complications. These findings have significant implications for global provision of elective surgical care. We aimed to determine the impact of pre-operative isolation on postoperative pulmonary complications after elective surgery during the global SARS-CoV-2 pandemic. We performed an international prospective cohort study including patients undergoing elective surgery in October 2020. Isolation was defined as the period before surgery during which patients did not leave their house or receive visitors from outside their household. The primary outcome was postoperative pulmonary complications, adjusted in multivariable models for measured confounders. Pre-defined sub-group analyses were performed for the primary outcome. A total of 96,454 patients from 114 countries were included and overall, 26,948 (27.9%) patients isolated before surgery. Postoperative pulmonary complications were recorded in 1947 (2.0%) patients of which 227 (11.7%) were associated with SARS-CoV-2 infection. Patients who isolated pre-operatively were older, had more respiratory comorbidities and were more commonly from areas of high SARS-CoV-2 incidence and high-income countries. Although the overall rates of postoperative pulmonary complications were similar in those that isolated and those that did not (2.1% vs 2.0%, respectively), isolation was associated with higher rates of postoperative pulmonary complications after adjustment (adjusted OR 1.20, 95%CI 1.05–1.36, p = 0.005). Sensitivity analyses revealed no further differences when patients were categorised by: pre-operative testing; use of COVID-19-free pathways; or community SARS-CoV-2 prevalence. The rate of postoperative pulmonary complications increased with periods of isolation longer than 3 days, with an OR (95%CI) at 4–7 days or ≥ 8 days of 1.25 (1.04–1.48), p = 0.015 and 1.31 (1.11–1.55), p = 0.001, respectively. Isolation before elective surgery might be associated with a small but clinically important increased risk of postoperative pulmonary complications. Longer periods of isolation showed no reduction in the risk of postoperative pulmonary complications. These findings have significant implications for global provision of elective surgical care